09:20 AM EST, 11/14/2024 (MT Newswires) -- Health care stocks were advancing pre-bell Thursday as the iShares Biotechnology ETF (IBB) was marginally higher and the Health Care Select Sector SPDR Fund ( XLV ) was up 0.1% recently.

ClearPoint Neuro ( CLPT ) shares were up nearly 10% after the company said the US Food and Drug Administration has granted De Novo marketing authorization for its SmartFlow Neuro Cannula for the delivery of PTC Therapeutics' ( PTCT ) Kebilidi gene therapy to targeted regions within the brain.

PTC Therapeutics ( PTCT ) shares were over 2% higher after the company said the US Food and Drug Administration has accelerated approval of Kebilidi, the company's gene therapy for aromatic L-amino acid decarboxylase deficiency.

BeiGene ( BGNE ) shares were 0.8% higher after the company said it plans to change its name to BeOne Medicines, subject to shareholder approval.